Pro-Inflammatory wnt5a and Anti-Inflammatory sFRP5 Are Differentially Regulated by Nutritional Factors in Obese Human Subjects

Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found t...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 7; no. 2; p. e32437
Main Authors Schulte, Dominik M., Müller, Nike, Neumann, Katrin, Oberhäuser, Frank, Faust, Michael, Güdelhöfer, Heike, Brandt, Burkhard, Krone, Wilhelm, Laudes, Matthias
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 23.02.2012
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0032437

Cover

Abstract Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine (1) whether obese human subjects exhibit increased serum concentrations of wnt5a and (2) whether wnt5a and/or sFRP5 serum concentrations in obese subjects can be influenced by caloric restriction. 23 obese human subjects (BMI 44.1 ± 1.1 kg/m(2)) and 12 age- and sex-matched lean controls (BMI 22.3 ± 0.4 kg/m(2)) were included in the study. Obese subjects were treated with a very low-calorie diet (approximately 800 kcal/d) for 12 weeks. Body composition was assessed by impedance analysis, insulin sensitivity was estimated by HOMA-IR and the leptin-to-adiponectin ratio and wnt5a and sFRP5 serum concentrations were measured by ELISA. sFRP5 expression in human adipose tissue biopsies was further determined on protein level by immunohistology. Pro-inflammatory wnt5a was not measurable in any serum sample of lean control subjects. In patients with obesity, however, wnt5a became significantly detectable consistent with low grade inflammation in such subjects. Caloric restriction resulted in a weight loss from 131.9 ± 4.0 to 112.3 ± 3.2 kg in the obese patients group. This was accompanied by a significant decrease of HOMA-IR and leptin-to-adiponectin ratio, indicating improved insulin sensitivity. Interestingly, these metabolic improvements were associated with a significant increase in serum concentrations of the anti-inflammatory factor and wnt5a-inhibitor sFRP5. Obesity is associated with elevated serum levels of pro-inflammatory wnt5a in humans. Furthermore, caloric restriction beneficially affects serum concentrations of anti-inflammatory sFRP5 in such subjects. These findings suggest a novel regulatory system in low grade inflammation in obesity, which can be influenced by nutritional therapy.
AbstractList Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine (1) whether obese human subjects exhibit increased serum concentrations of wnt5a and (2) whether wnt5a and/or sFRP5 serum concentrations in obese subjects can be influenced by caloric restriction. 23 obese human subjects (BMI 44.1±1.1 kg/m.sup.2) and 12 age- and sex-matched lean controls (BMI 22.3±0.4 kg/m.sup.2) were included in the study. Obese subjects were treated with a very low-calorie diet (approximately 800 kcal/d) for 12 weeks. Body composition was assessed by impedance analysis, insulin sensitivity was estimated by HOMA-IR and the leptin-to-adiponectin ratio and wnt5a and sFRP5 serum concentrations were measured by ELISA. sFRP5 expression in human adipose tissue biopsies was further determined on protein level by immunohistology. Obesity is associated with elevated serum levels of pro-inflammatory wnt5a in humans. Furthermore, caloric restriction beneficially affects serum concentrations of anti-inflammatory sFRP5 in such subjects. These findings suggest a novel regulatory system in low grade inflammation in obesity, which can be influenced by nutritional therapy.
Background Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine (1) whether obese human subjects exhibit increased serum concentrations of wnt5a and (2) whether wnt5a and/or sFRP5 serum concentrations in obese subjects can be influenced by caloric restriction. Methodology 23 obese human subjects (BMI 44.1±1.1 kg/m.sup.2) and 12 age- and sex-matched lean controls (BMI 22.3±0.4 kg/m.sup.2) were included in the study. Obese subjects were treated with a very low-calorie diet (approximately 800 kcal/d) for 12 weeks. Body composition was assessed by impedance analysis, insulin sensitivity was estimated by HOMA-IR and the leptin-to-adiponectin ratio and wnt5a and sFRP5 serum concentrations were measured by ELISA. sFRP5 expression in human adipose tissue biopsies was further determined on protein level by immunohistology. Principal Findings Pro-inflammatory wnt5a was not measurable in any serum sample of lean control subjects. In patients with obesity, however, wnt5a became significantly detectable consistent with low grade inflammation in such subjects. Caloric restriction resulted in a weight loss from 131.9±4.0 to 112.3±3.2 kg in the obese patients group. This was accompanied by a significant decrease of HOMA-IR and leptin-to-adiponectin ratio, indicating improved insulin sensitivity. Interestingly, these metabolic improvements were associated with a significant increase in serum concentrations of the anti-inflammatory factor and wnt5a-inhibitor sFRP5. Conclusions/Significance Obesity is associated with elevated serum levels of pro-inflammatory wnt5a in humans. Furthermore, caloric restriction beneficially affects serum concentrations of anti-inflammatory sFRP5 in such subjects. These findings suggest a novel regulatory system in low grade inflammation in obesity, which can be influenced by nutritional therapy.
Background Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine (1) whether obese human subjects exhibit increased serum concentrations of wnt5a and (2) whether wnt5a and/or sFRP5 serum concentrations in obese subjects can be influenced by caloric restriction. Methodology 23 obese human subjects (BMI 44.1±1.1 kg/m2) and 12 age- and sex-matched lean controls (BMI 22.3±0.4 kg/m2) were included in the study. Obese subjects were treated with a very low-calorie diet (approximately 800 kcal/d) for 12 weeks. Body composition was assessed by impedance analysis, insulin sensitivity was estimated by HOMA-IR and the leptin-to-adiponectin ratio and wnt5a and sFRP5 serum concentrations were measured by ELISA. sFRP5 expression in human adipose tissue biopsies was further determined on protein level by immunohistology. Principal Findings Pro-inflammatory wnt5a was not measurable in any serum sample of lean control subjects. In patients with obesity, however, wnt5a became significantly detectable consistent with low grade inflammation in such subjects. Caloric restriction resulted in a weight loss from 131.9±4.0 to 112.3±3.2 kg in the obese patients group. This was accompanied by a significant decrease of HOMA-IR and leptin-to-adiponectin ratio, indicating improved insulin sensitivity. Interestingly, these metabolic improvements were associated with a significant increase in serum concentrations of the anti-inflammatory factor and wnt5a-inhibitor sFRP5. Conclusions/Significance Obesity is associated with elevated serum levels of pro-inflammatory wnt5a in humans. Furthermore, caloric restriction beneficially affects serum concentrations of anti-inflammatory sFRP5 in such subjects. These findings suggest a novel regulatory system in low grade inflammation in obesity, which can be influenced by nutritional therapy.
Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine (1) whether obese human subjects exhibit increased serum concentrations of wnt5a and (2) whether wnt5a and/or sFRP5 serum concentrations in obese subjects can be influenced by caloric restriction.BACKGROUNDObesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine (1) whether obese human subjects exhibit increased serum concentrations of wnt5a and (2) whether wnt5a and/or sFRP5 serum concentrations in obese subjects can be influenced by caloric restriction.23 obese human subjects (BMI 44.1 ± 1.1 kg/m(2)) and 12 age- and sex-matched lean controls (BMI 22.3 ± 0.4 kg/m(2)) were included in the study. Obese subjects were treated with a very low-calorie diet (approximately 800 kcal/d) for 12 weeks. Body composition was assessed by impedance analysis, insulin sensitivity was estimated by HOMA-IR and the leptin-to-adiponectin ratio and wnt5a and sFRP5 serum concentrations were measured by ELISA. sFRP5 expression in human adipose tissue biopsies was further determined on protein level by immunohistology.METHODOLOGY23 obese human subjects (BMI 44.1 ± 1.1 kg/m(2)) and 12 age- and sex-matched lean controls (BMI 22.3 ± 0.4 kg/m(2)) were included in the study. Obese subjects were treated with a very low-calorie diet (approximately 800 kcal/d) for 12 weeks. Body composition was assessed by impedance analysis, insulin sensitivity was estimated by HOMA-IR and the leptin-to-adiponectin ratio and wnt5a and sFRP5 serum concentrations were measured by ELISA. sFRP5 expression in human adipose tissue biopsies was further determined on protein level by immunohistology.Pro-inflammatory wnt5a was not measurable in any serum sample of lean control subjects. In patients with obesity, however, wnt5a became significantly detectable consistent with low grade inflammation in such subjects. Caloric restriction resulted in a weight loss from 131.9 ± 4.0 to 112.3 ± 3.2 kg in the obese patients group. This was accompanied by a significant decrease of HOMA-IR and leptin-to-adiponectin ratio, indicating improved insulin sensitivity. Interestingly, these metabolic improvements were associated with a significant increase in serum concentrations of the anti-inflammatory factor and wnt5a-inhibitor sFRP5.PRINCIPAL FINDINGSPro-inflammatory wnt5a was not measurable in any serum sample of lean control subjects. In patients with obesity, however, wnt5a became significantly detectable consistent with low grade inflammation in such subjects. Caloric restriction resulted in a weight loss from 131.9 ± 4.0 to 112.3 ± 3.2 kg in the obese patients group. This was accompanied by a significant decrease of HOMA-IR and leptin-to-adiponectin ratio, indicating improved insulin sensitivity. Interestingly, these metabolic improvements were associated with a significant increase in serum concentrations of the anti-inflammatory factor and wnt5a-inhibitor sFRP5.Obesity is associated with elevated serum levels of pro-inflammatory wnt5a in humans. Furthermore, caloric restriction beneficially affects serum concentrations of anti-inflammatory sFRP5 in such subjects. These findings suggest a novel regulatory system in low grade inflammation in obesity, which can be influenced by nutritional therapy.CONCLUSIONS/SIGNIFICANCEObesity is associated with elevated serum levels of pro-inflammatory wnt5a in humans. Furthermore, caloric restriction beneficially affects serum concentrations of anti-inflammatory sFRP5 in such subjects. These findings suggest a novel regulatory system in low grade inflammation in obesity, which can be influenced by nutritional therapy.
Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine (1) whether obese human subjects exhibit increased serum concentrations of wnt5a and (2) whether wnt5a and/or sFRP5 serum concentrations in obese subjects can be influenced by caloric restriction.23 obese human subjects (BMI 44.1 ± 1.1 kg/m(2)) and 12 age- and sex-matched lean controls (BMI 22.3 ± 0.4 kg/m(2)) were included in the study. Obese subjects were treated with a very low-calorie diet (approximately 800 kcal/d) for 12 weeks. Body composition was assessed by impedance analysis, insulin sensitivity was estimated by HOMA-IR and the leptin-to-adiponectin ratio and wnt5a and sFRP5 serum concentrations were measured by ELISA. sFRP5 expression in human adipose tissue biopsies was further determined on protein level by immunohistology.Pro-inflammatory wnt5a was not measurable in any serum sample of lean control subjects. In patients with obesity, however, wnt5a became significantly detectable consistent with low grade inflammation in such subjects. Caloric restriction resulted in a weight loss from 131.9 ± 4.0 to 112.3 ± 3.2 kg in the obese patients group. This was accompanied by a significant decrease of HOMA-IR and leptin-to-adiponectin ratio, indicating improved insulin sensitivity. Interestingly, these metabolic improvements were associated with a significant increase in serum concentrations of the anti-inflammatory factor and wnt5a-inhibitor sFRP5.Obesity is associated with elevated serum levels of pro-inflammatory wnt5a in humans. Furthermore, caloric restriction beneficially affects serum concentrations of anti-inflammatory sFRP5 in such subjects. These findings suggest a novel regulatory system in low grade inflammation in obesity, which can be influenced by nutritional therapy.
Background Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine (1) whether obese human subjects exhibit increased serum concentrations of wnt5a and (2) whether wnt5a and/or sFRP5 serum concentrations in obese subjects can be influenced by caloric restriction. Methodology 23 obese human subjects (BMI 44.1±1.1 kg/m 2 ) and 12 age- and sex-matched lean controls (BMI 22.3±0.4 kg/m 2 ) were included in the study. Obese subjects were treated with a very low-calorie diet (approximately 800 kcal/d) for 12 weeks. Body composition was assessed by impedance analysis, insulin sensitivity was estimated by HOMA-IR and the leptin-to-adiponectin ratio and wnt5a and sFRP5 serum concentrations were measured by ELISA. sFRP5 expression in human adipose tissue biopsies was further determined on protein level by immunohistology. Principal Findings Pro-inflammatory wnt5a was not measurable in any serum sample of lean control subjects. In patients with obesity, however, wnt5a became significantly detectable consistent with low grade inflammation in such subjects. Caloric restriction resulted in a weight loss from 131.9±4.0 to 112.3±3.2 kg in the obese patients group. This was accompanied by a significant decrease of HOMA-IR and leptin-to-adiponectin ratio, indicating improved insulin sensitivity. Interestingly, these metabolic improvements were associated with a significant increase in serum concentrations of the anti-inflammatory factor and wnt5a-inhibitor sFRP5. Conclusions/Significance Obesity is associated with elevated serum levels of pro-inflammatory wnt5a in humans. Furthermore, caloric restriction beneficially affects serum concentrations of anti-inflammatory sFRP5 in such subjects. These findings suggest a novel regulatory system in low grade inflammation in obesity, which can be influenced by nutritional therapy.
Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine (1) whether obese human subjects exhibit increased serum concentrations of wnt5a and (2) whether wnt5a and/or sFRP5 serum concentrations in obese subjects can be influenced by caloric restriction. 23 obese human subjects (BMI 44.1 ± 1.1 kg/m(2)) and 12 age- and sex-matched lean controls (BMI 22.3 ± 0.4 kg/m(2)) were included in the study. Obese subjects were treated with a very low-calorie diet (approximately 800 kcal/d) for 12 weeks. Body composition was assessed by impedance analysis, insulin sensitivity was estimated by HOMA-IR and the leptin-to-adiponectin ratio and wnt5a and sFRP5 serum concentrations were measured by ELISA. sFRP5 expression in human adipose tissue biopsies was further determined on protein level by immunohistology. Pro-inflammatory wnt5a was not measurable in any serum sample of lean control subjects. In patients with obesity, however, wnt5a became significantly detectable consistent with low grade inflammation in such subjects. Caloric restriction resulted in a weight loss from 131.9 ± 4.0 to 112.3 ± 3.2 kg in the obese patients group. This was accompanied by a significant decrease of HOMA-IR and leptin-to-adiponectin ratio, indicating improved insulin sensitivity. Interestingly, these metabolic improvements were associated with a significant increase in serum concentrations of the anti-inflammatory factor and wnt5a-inhibitor sFRP5. Obesity is associated with elevated serum levels of pro-inflammatory wnt5a in humans. Furthermore, caloric restriction beneficially affects serum concentrations of anti-inflammatory sFRP5 in such subjects. These findings suggest a novel regulatory system in low grade inflammation in obesity, which can be influenced by nutritional therapy.
Audience Academic
Author Schulte, Dominik M.
Laudes, Matthias
Brandt, Burkhard
Müller, Nike
Oberhäuser, Frank
Güdelhöfer, Heike
Krone, Wilhelm
Neumann, Katrin
Faust, Michael
AuthorAffiliation University of Cambridge, United Kingdom
1 Department I of Internal Medicine, University of Kiel, Kiel, Germany
2 Center of Endocrinology, Diabetes and Preventive Medicine, University of Cologne (Germany), Köln, Germany
3 Institute for Clinical Chemistry, University of Kiel, Kiel, Germany
AuthorAffiliation_xml – name: 3 Institute for Clinical Chemistry, University of Kiel, Kiel, Germany
– name: University of Cambridge, United Kingdom
– name: 2 Center of Endocrinology, Diabetes and Preventive Medicine, University of Cologne (Germany), Köln, Germany
– name: 1 Department I of Internal Medicine, University of Kiel, Kiel, Germany
Author_xml – sequence: 1
  givenname: Dominik M.
  surname: Schulte
  fullname: Schulte, Dominik M.
– sequence: 2
  givenname: Nike
  surname: Müller
  fullname: Müller, Nike
– sequence: 3
  givenname: Katrin
  surname: Neumann
  fullname: Neumann, Katrin
– sequence: 4
  givenname: Frank
  surname: Oberhäuser
  fullname: Oberhäuser, Frank
– sequence: 5
  givenname: Michael
  surname: Faust
  fullname: Faust, Michael
– sequence: 6
  givenname: Heike
  surname: Güdelhöfer
  fullname: Güdelhöfer, Heike
– sequence: 7
  givenname: Burkhard
  surname: Brandt
  fullname: Brandt, Burkhard
– sequence: 8
  givenname: Wilhelm
  surname: Krone
  fullname: Krone, Wilhelm
– sequence: 9
  givenname: Matthias
  surname: Laudes
  fullname: Laudes, Matthias
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22384249$$D View this record in MEDLINE/PubMed
BookMark eNqNk19v0zAUxSM0xP7AN0AQCQnEQ0tsx3GyB6RqMFZpolMHvFquc925cuJiO4y-8NlxaDct04SmPDi6_p3j63OTw2SvtS0kyUuUjRFh6MPKdq4VZryO5XGWEZwT9iQ5QBXBowJnZO_O-35y6P0qyygpi-JZso8xKXOcVwfJnwtnR9NWGdE0Ili3Sa_bQEUq2jqdtEEP9_zp_IKmEwfpJ60UOIiEMGaTzmHZGRGgTheb9GsXnA7axu7SUyGj0qe6TWcL8JCedY1o08tusQIZ_PPkqRLGw4vdepR8P_387eRsdD77Mj2ZnI8koyyMqMwpxhjVTKKqEkzVssgBU5zRGhglOUhcVbKUSKlKEpThYpExKRTkrKiqghwlr7e-a2M930XnOSIxCBrxKhLTLVFbseJrpxvhNtwKzf8VrFty4YKWBniOMAFKlappnQMiC6EQiS4Zg0pgBtGLbr26di021zGhW0OU8X56Ny3wfnp8N72o-7jrsls0UMsYrxNm0Mxwp9VXfGl_cYJLWpQ0GrzbGTj7swMfeKO9BGNEC7bzvMIFoqwk_XXf3CMfDmVHLUW8t26VjcfK3pNPcsYyimjZtz1-gIpPDY2W8YJKx_pA8H4giEyA32EpOu_59HL-eHb2Y8i-vcNegTDhylvT9d-iH4Kv7gZ9m_DNfxGBfAtIZ713oB47wON7MqmD6I-PiWjzf_FfyuQ1UQ
CitedBy_id crossref_primary_10_1016_j_bbrc_2023_08_008
crossref_primary_10_1155_2014_978463
crossref_primary_10_1016_j_metabol_2019_154029
crossref_primary_10_1038_s41419_022_04847_0
crossref_primary_10_1074_jbc_M115_693937
crossref_primary_10_3390_biomedicines11020313
crossref_primary_10_1007_s12015_013_9486_8
crossref_primary_10_1210_jc_2014_1191
crossref_primary_10_2337_db17_0067
crossref_primary_10_1016_j_nut_2019_03_009
crossref_primary_10_1002_dmrr_2896
crossref_primary_10_3389_fphys_2020_578966
crossref_primary_10_1111_jre_12659
crossref_primary_10_3390_ijms22136895
crossref_primary_10_3390_ijms23179871
crossref_primary_10_1111_jcpe_13087
crossref_primary_10_1126_scitranslmed_aav5055
crossref_primary_10_1186_s13048_021_00847_4
crossref_primary_10_3390_ijms18010008
crossref_primary_10_3390_nu16193328
crossref_primary_10_1016_j_gendis_2023_04_042
crossref_primary_10_7759_cureus_80408
crossref_primary_10_1172_JCI64196
crossref_primary_10_1002_cam4_7352
crossref_primary_10_1016_j_imlet_2014_08_015
crossref_primary_10_1210_jc_2018_01007
crossref_primary_10_1007_s11055_022_01261_z
crossref_primary_10_1042_BSR20180011
crossref_primary_10_3389_fphys_2020_568800
crossref_primary_10_1024_0300_9831_a000509
crossref_primary_10_1080_10495398_2016_1178138
crossref_primary_10_1038_s41598_022_18354_x
crossref_primary_10_1530_JME_14_0037
crossref_primary_10_3390_nu13072459
crossref_primary_10_1089_jir_2018_0154
crossref_primary_10_1017_S0007114518002726
crossref_primary_10_1111_cen_12361
crossref_primary_10_2217_fon_2020_0356
crossref_primary_10_3390_biom14070768
crossref_primary_10_1016_j_orcp_2023_02_002
crossref_primary_10_1186_s13018_021_02260_5
crossref_primary_10_1371_journal_pone_0085906
crossref_primary_10_1186_s13098_018_0343_4
crossref_primary_10_1038_pr_2014_29
crossref_primary_10_1093_rheumatology_keu167
crossref_primary_10_1111_eci_12052
crossref_primary_10_1074_jbc_M116_758078
crossref_primary_10_1002_biof_1074
crossref_primary_10_1096_fj_15_271171
crossref_primary_10_1111_exd_12413
crossref_primary_10_3109_14767058_2015_1052399
crossref_primary_10_3390_ijms20030595
crossref_primary_10_1155_2017_5350267
crossref_primary_10_1016_j_heliyon_2024_e35905
crossref_primary_10_1007_s12020_013_0088_7
crossref_primary_10_1080_21655979_2022_2070964
crossref_primary_10_1007_s12020_021_02793_z
crossref_primary_10_1007_s11033_016_4050_7
crossref_primary_10_1007_s13410_019_00790_7
crossref_primary_10_1016_j_yexcr_2018_02_012
crossref_primary_10_1007_s00125_013_3030_x
crossref_primary_10_1007_s00198_016_3873_3
crossref_primary_10_3389_fphar_2021_619588
crossref_primary_10_1172_JCI63604
crossref_primary_10_1002_dmrr_2599
crossref_primary_10_3389_fendo_2021_712217
crossref_primary_10_3390_nu16183133
crossref_primary_10_1097_MED_0000000000000223
crossref_primary_10_1111_dom_12155
crossref_primary_10_1186_s12933_017_0591_x
crossref_primary_10_1002_oby_21787
crossref_primary_10_1210_jc_2014_2419
crossref_primary_10_1371_journal_pone_0083819
crossref_primary_10_1093_bbb_zbae053
crossref_primary_10_1111_nyas_12958
crossref_primary_10_1111_cei_12484
crossref_primary_10_1111_jdi_12071
crossref_primary_10_2147_DMSO_S242657
crossref_primary_10_3389_fphys_2020_00070
crossref_primary_10_1371_journal_pone_0094282
crossref_primary_10_1111_liv_12757
crossref_primary_10_1016_j_biochi_2015_05_007
crossref_primary_10_1016_j_atherosclerosis_2014_01_019
crossref_primary_10_1371_journal_pone_0213650
crossref_primary_10_1016_j_diabres_2012_11_026
crossref_primary_10_1002_dmrr_2426
crossref_primary_10_1371_journal_pone_0067712
crossref_primary_10_1590_S1984_82502014000400003
crossref_primary_10_3390_ijms25147948
crossref_primary_10_1111_jcmm_15023
crossref_primary_10_1007_s11033_018_4360_z
crossref_primary_10_1016_j_bjorl_2018_07_002
crossref_primary_10_1161_CIRCRESAHA_115_306885
crossref_primary_10_1177_1358863X16666693
Cites_doi 10.2337/db08-1180
10.2337/db11-0004
10.1074/jbc.M109.054338
10.1007/s00125-009-1508-3
10.1038/nature01570
10.1152/ajpendo.00709.2010
10.1038/ijo.2011.6
10.1016/j.bbalip.2009.12.006
10.1074/jbc.M600274200
10.1074/jbc.M501080200
10.1074/jbc.274.37.26287
10.1161/ATVBAHA.107.157438
10.1126/science.1188280
10.1242/jcs.02975
10.1126/science.289.5481.950
10.2119/2007-00119.Tilg
10.1038/ijo.2010.107
10.1080/03009740601179605
10.1900/RDS.2007.4.77
10.2337/diabetes.53.12.3274
10.2337/db06-1339
10.1159/000088261
10.1371/journal.pone.0014328
10.1007/s00125-006-0144-4
10.1016/S0014-5793(00)01250-3
10.1056/NEJMoa065213
ContentType Journal Article
Copyright COPYRIGHT 2012 Public Library of Science
2012 Schulte et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Schulte et al. 2012
Copyright_xml – notice: COPYRIGHT 2012 Public Library of Science
– notice: 2012 Schulte et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Schulte et al. 2012
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1371/journal.pone.0032437
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & allied health premium.
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection (subscription)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Computer Science Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agriculture Science Database
Health & Medical Collection (Alumni Edition)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database (subscription)
Nursing & Allied Health Premium
AAdvanced Technologies & Aerospace Database (subscription)
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database (subscripiton)
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList


Agricultural Science Database
MEDLINE - Academic




MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
Biology
DocumentTitleAlternate wnt5a and sFRP5 in Human Obesity
EISSN 1932-6203
ExternalDocumentID 1323851029
oai_doaj_org_article_4123e55ffd5d4e13baf1351007e9a27e
10.1371/journal.pone.0032437
PMC3285685
2936604291
A477051587
22384249
10_1371_journal_pone_0032437
Genre Journal Article
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESTFP
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPNFZ
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PTHSS
PUEGO
PYCSY
RIG
RNS
RPM
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
PV9
RZL
BBORY
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
5PM
ADTOC
UNPAY
AAPBV
ABPTK
ID FETCH-LOGICAL-c757t-5c452221d7c199a7fdc64e25205de7534ec299c8c1ff9c31026b07cafe4769963
IEDL.DBID M48
ISSN 1932-6203
IngestDate Sun Sep 03 00:14:33 EDT 2023
Tue Oct 14 19:04:35 EDT 2025
Sun Oct 26 04:17:19 EDT 2025
Tue Sep 30 16:42:33 EDT 2025
Wed Oct 01 17:07:21 EDT 2025
Tue Oct 07 06:58:20 EDT 2025
Mon Oct 20 22:07:30 EDT 2025
Mon Oct 20 16:47:36 EDT 2025
Thu Oct 16 15:24:21 EDT 2025
Thu Oct 16 15:19:17 EDT 2025
Thu May 22 21:09:53 EDT 2025
Mon Jul 21 05:34:26 EDT 2025
Thu Apr 24 23:02:24 EDT 2025
Wed Oct 01 04:40:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
cc-by
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c757t-5c452221d7c199a7fdc64e25205de7534ec299c8c1ff9c31026b07cafe4769963
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Conceived and designed the experiments: WK ML. Performed the experiments: DS NM KN FO MF HG BB. Analyzed the data: DS ML. Wrote the paper: WK ML.
OpenAccessLink https://doaj.org/article/4123e55ffd5d4e13baf1351007e9a27e
PMID 22384249
PQID 1323851029
PQPubID 1436336
PageCount e32437
ParticipantIDs plos_journals_1323851029
doaj_primary_oai_doaj_org_article_4123e55ffd5d4e13baf1351007e9a27e
unpaywall_primary_10_1371_journal_pone_0032437
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3285685
proquest_miscellaneous_926157839
proquest_journals_1323851029
gale_infotracmisc_A477051587
gale_infotracacademiconefile_A477051587
gale_incontextgauss_ISR_A477051587
gale_incontextgauss_IOV_A477051587
gale_healthsolutions_A477051587
pubmed_primary_22384249
crossref_primary_10_1371_journal_pone_0032437
crossref_citationtrail_10_1371_journal_pone_0032437
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-02-23
PublicationDateYYYYMMDD 2012-02-23
PublicationDate_xml – month: 02
  year: 2012
  text: 2012-02-23
  day: 23
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2012
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References H Tilg (ref1) 2008; 14
CP Wang (ref8) 2007; 4
C Lagathu (ref19) 2010; 34
A Rosenvinge (ref10) 2007; 36
R Bilkovski (ref13) 2011; 35
S Virtue (ref9) 2010; 1801
O Schultz (ref4) 2010; 5
L Zhao (ref2) 2011; 301
R Bilkovski (ref12) 2010; 285
SE Ross (ref17) 2000; 289
JA Kennell (ref23) 2005; 280
C Lagathu (ref15) 2009; 58
M Laudes (ref18) 2011; 46
L Zhang (ref21) 2006; 281
H Dominguez (ref11) 2005; 42
C Christodoulides (ref20) 2006; 119
CM Larsen (ref5) 2007; 356
K Takemaru (ref22) 2003; 422
C Pereira (ref27) 2008; 28
N Ouchi (ref14) 2010; 329
H Xu (ref6) 1999; 274
WS Wright (ref24) 2007; 56
C Christodoulides (ref25) 2006; 49
JD Schertzer (ref3) 2011; 60
JK Sethi (ref7) 2000; 469
FM Finucane (ref16) 2009; 52
K Almind (ref26) 2004; 53
16446366 - J Biol Chem. 2006 Mar 31;281(13):8607-12
21285942 - Int J Obes (Lond). 2011 Nov;35(11):1450-4
21693690 - Am J Physiol Endocrinol Metab. 2011 Oct;301(4):E587-98
10473584 - J Biol Chem. 1999 Sep 10;274(37):26287-95
17429083 - N Engl J Med. 2007 Apr 12;356(15):1517-26
19756488 - Diabetologia. 2009 Nov;52(11):2345-9
18235842 - Mol Med. 2008 Mar-Apr;14(3-4):222-31
20056169 - Biochim Biophys Acta. 2010 Mar;1801(3):338-49
10708760 - FEBS Lett. 2000 Mar 3;469(1):77-82
20514047 - Int J Obes (Lond). 2010 Dec;34(12):1695-705
17476613 - Scand J Rheumatol. 2007 Mar-Apr;36(2):91-6
18174455 - Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):504-10
21715553 - Diabetes. 2011 Sep;60(9):2206-15
17823691 - Rev Diabet Stud. 2007 Summer;4(2):77-84
20558665 - Science. 2010 Jul 23;329(5990):454-7
12712206 - Nature. 2003 Apr 24;422(6934):905-9
15849360 - J Biol Chem. 2005 Jun 24;280(25):24004-10
15561960 - Diabetes. 2004 Dec;53(12):3274-85
21179199 - PLoS One. 2010;5(12):e14328
17259372 - Diabetes. 2007 Feb;56(2):295-303
16155368 - J Vasc Res. 2005 Nov-Dec;42(6):517-25
10937998 - Science. 2000 Aug 11;289(5481):950-3
21247979 - J Mol Endocrinol. 2011 Apr;46(2):R65-72
16477437 - Diabetologia. 2006 Apr;49(4):678-84
19073771 - Diabetes. 2009 Mar;58(3):609-19
20032469 - J Biol Chem. 2010 Feb 26;285(9):6170-8
16763196 - J Cell Sci. 2006 Jun 15;119(Pt 12):2613-20
References_xml – volume: 58
  start-page: 609
  year: 2009
  ident: ref15
  article-title: Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/beta-catenin signaling network.
  publication-title: Diabetes
  doi: 10.2337/db08-1180
– volume: 60
  start-page: 2206
  year: 2011
  ident: ref3
  article-title: NOD1 Activators Link Innate Immunity to Insulin Resistance.
  publication-title: Diabetes
  doi: 10.2337/db11-0004
– volume: 285
  start-page: 6170
  year: 2010
  ident: ref12
  article-title: Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.054338
– volume: 52
  start-page: 2345
  year: 2009
  ident: ref16
  article-title: Correlation of the leptin∶adiponectin ratio with measures of insulin resistance in non-diabetic individuals.
  publication-title: Diabetologia
  doi: 10.1007/s00125-009-1508-3
– volume: 422
  start-page: 905
  year: 2003
  ident: ref22
  article-title: Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway.
  publication-title: Nature
  doi: 10.1038/nature01570
– volume: 301
  start-page: E587
  year: 2011
  ident: ref2
  article-title: NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes.
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00709.2010
– volume: 35
  start-page: 1450
  year: 2011
  ident: ref13
  article-title: Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans.
  publication-title: Int J Obes
  doi: 10.1038/ijo.2011.6
– volume: 1801
  start-page: 338
  year: 2010
  ident: ref9
  article-title: Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-an allostatic perspective.
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbalip.2009.12.006
– volume: 281
  start-page: 8607
  year: 2006
  ident: ref21
  article-title: Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M600274200
– volume: 280
  start-page: 24004
  year: 2005
  ident: ref23
  article-title: Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M501080200
– volume: 274
  start-page: 26287
  year: 1999
  ident: ref6
  article-title: Transmembrane tumor necrosis factor (TNF)-alpha inhibits adipocyte differentiation by selectively activating TNF receptor 1.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.274.37.26287
– volume: 28
  start-page: 504
  year: 2008
  ident: ref27
  article-title: Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10.
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.157438
– volume: 46
  start-page: R65
  year: 2011
  ident: ref18
  article-title: Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes.
  publication-title: J Mol Endocrinol
– volume: 329
  start-page: 454
  year: 2010
  ident: ref14
  article-title: Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.
  publication-title: Science
  doi: 10.1126/science.1188280
– volume: 119
  start-page: 2613
  year: 2006
  ident: ref20
  article-title: The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis.
  publication-title: J Cell Sci
  doi: 10.1242/jcs.02975
– volume: 289
  start-page: 950
  year: 2000
  ident: ref17
  article-title: Inhibition of adipogenesis by Wnt signaling.
  publication-title: Science
  doi: 10.1126/science.289.5481.950
– volume: 14
  start-page: 222
  year: 2008
  ident: ref1
  article-title: Inflammatory mechanism in the regulation of insulin resistance.
  publication-title: Mol Med
  doi: 10.2119/2007-00119.Tilg
– volume: 34
  start-page: 1695
  year: 2010
  ident: ref19
  article-title: Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity.
  publication-title: Int J Obes
  doi: 10.1038/ijo.2010.107
– volume: 36
  start-page: 91
  year: 2007
  ident: ref10
  article-title: Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy.
  publication-title: Scand J Rheumatol
  doi: 10.1080/03009740601179605
– volume: 4
  start-page: 77
  year: 2007
  ident: ref8
  article-title: Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.
  publication-title: Rev Diabet Stud
  doi: 10.1900/RDS.2007.4.77
– volume: 53
  start-page: 3274
  year: 2004
  ident: ref26
  article-title: Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice.
  publication-title: Diabetes
  doi: 10.2337/diabetes.53.12.3274
– volume: 56
  start-page: 295
  year: 2007
  ident: ref24
  article-title: Wnt10b inhibits obesity in ob/ob and agouti mice.
  publication-title: Diabetes
  doi: 10.2337/db06-1339
– volume: 42
  start-page: 517
  year: 2005
  ident: ref11
  article-title: Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes.
  publication-title: J Vasc Res
  doi: 10.1159/000088261
– volume: 5
  start-page: e14328
  year: 2010
  ident: ref4
  article-title: Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0014328
– volume: 49
  start-page: 678
  year: 2006
  ident: ref25
  article-title: WNT10B mutations in human obesity.
  publication-title: Diabetologia
  doi: 10.1007/s00125-006-0144-4
– volume: 469
  start-page: 77
  year: 2000
  ident: ref7
  article-title: Characterisation of receptor-specific TNFalpha functions in adipocyte cell lines lacking type 1 and 2 TNF receptors.
  publication-title: FEBS Lett
  doi: 10.1016/S0014-5793(00)01250-3
– volume: 356
  start-page: 1517
  year: 2007
  ident: ref5
  article-title: Interleukin-1-receptor antagonist in type 2 diabetes mellitus.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa065213
– reference: 15561960 - Diabetes. 2004 Dec;53(12):3274-85
– reference: 17823691 - Rev Diabet Stud. 2007 Summer;4(2):77-84
– reference: 20514047 - Int J Obes (Lond). 2010 Dec;34(12):1695-705
– reference: 17429083 - N Engl J Med. 2007 Apr 12;356(15):1517-26
– reference: 17259372 - Diabetes. 2007 Feb;56(2):295-303
– reference: 21179199 - PLoS One. 2010;5(12):e14328
– reference: 16446366 - J Biol Chem. 2006 Mar 31;281(13):8607-12
– reference: 10473584 - J Biol Chem. 1999 Sep 10;274(37):26287-95
– reference: 20558665 - Science. 2010 Jul 23;329(5990):454-7
– reference: 17476613 - Scand J Rheumatol. 2007 Mar-Apr;36(2):91-6
– reference: 20032469 - J Biol Chem. 2010 Feb 26;285(9):6170-8
– reference: 10937998 - Science. 2000 Aug 11;289(5481):950-3
– reference: 19073771 - Diabetes. 2009 Mar;58(3):609-19
– reference: 21285942 - Int J Obes (Lond). 2011 Nov;35(11):1450-4
– reference: 16477437 - Diabetologia. 2006 Apr;49(4):678-84
– reference: 19756488 - Diabetologia. 2009 Nov;52(11):2345-9
– reference: 18235842 - Mol Med. 2008 Mar-Apr;14(3-4):222-31
– reference: 20056169 - Biochim Biophys Acta. 2010 Mar;1801(3):338-49
– reference: 12712206 - Nature. 2003 Apr 24;422(6934):905-9
– reference: 16763196 - J Cell Sci. 2006 Jun 15;119(Pt 12):2613-20
– reference: 10708760 - FEBS Lett. 2000 Mar 3;469(1):77-82
– reference: 21715553 - Diabetes. 2011 Sep;60(9):2206-15
– reference: 18174455 - Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):504-10
– reference: 16155368 - J Vasc Res. 2005 Nov-Dec;42(6):517-25
– reference: 15849360 - J Biol Chem. 2005 Jun 24;280(25):24004-10
– reference: 21693690 - Am J Physiol Endocrinol Metab. 2011 Oct;301(4):E587-98
– reference: 21247979 - J Mol Endocrinol. 2011 Apr;46(2):R65-72
SSID ssj0053866
Score 2.4109309
Snippet Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by...
Background Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but...
Background Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but...
SourceID plos
doaj
unpaywall
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e32437
SubjectTerms Adipocytes
Adipocytes - cytology
Adiponectin
Adipose tissue
Adipose Tissue - metabolism
Adult
Analysis
Anti-inflammatory agents
Biology
Body Composition
Body composition (biology)
Body mass
Body Mass Index
Body weight loss
Case-Control Studies
Cytokines
Dietary restrictions
Enzyme-linked immunosorbent assay
Enzyme-Linked Immunosorbent Assay - methods
Eye Proteins - biosynthesis
Eye Proteins - genetics
Female
Gene Expression Regulation
Humans
Hypocaloric diet
Infiltration
Inflammation
Infrared radiation
Inhibitors
Insulin
Insulin resistance
Leptin
Macrophages
Male
Medicine
Membrane Proteins - biosynthesis
Membrane Proteins - genetics
Middle Aged
Models, Biological
Nutrient deficiency
Nutrition therapy
Nutritional Sciences
Obesity
Obesity - blood
Obesity - genetics
Patients
Physiological aspects
Proto-Oncogene Proteins - biosynthesis
Proto-Oncogene Proteins - genetics
Rodents
Sensitivity
Sensitivity analysis
Serum levels
Type 2 diabetes
Wnt protein
Wnt Proteins - biosynthesis
Wnt Proteins - genetics
Wnt-5a Protein
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELXQXuCCKF8NFLAQEnDINnHsOD4WxKogAVWhqLfIcWxYKTirTaJqL_x2xokTNaJSe-Cwl_Vkdz3zZjyztt8g9ArKHs5FrEJKiAjBE3lYELfhmgoqtWSSaXdR-POX9PiMfjpn55dafbkzYQM98KC4QwqhVTNmTMlKquOkkMY1lYOlTQtJuHbRN8rEWEwNMRi8OE39RbmEx4feLstNbfUScOxY-GYLUc_XP0Xlxaaqm6tSzn9PTt7u7EbuLmRVXVqWVvfQXZ9P4qNhHnvolrb30Z732Aa_8bTSbx-gPyfbOgQ8AQR-91vr-MK2TGJpS3i16_lYszo9YVhuNR5bqEAoqKod3g7N63WJix22I5c__ATfuQevLa4L3Wjct__DTVe4v3qah-hs9eH7--PQd18IFWe8DZlyZOskLrmKhZDclCqlmjCwZKmhyKFawVKmMhUbIxRkiSQtIq6k0ZSnUEUlj9DCgr73EZaJShiPOC-jhBpRSklLwQqSGkCCMFGAktEUufLU5K5DRpX3-20cSpRBm7kzYO4NGKBwemozUHNcI__OWXmSdcTa_RsAt9zDLb8ObgF64TCSD7dUp_CQH1HOXbucDL7mZS_hyDWsO73zU3ZNk3_8-uMGQt9OZ0KvvZCpQR1K-hsTMCdH2jWTPJhJQohQs-F9h-hRKw3oCDI1mBUR8OSI8quH8TTsPtSdyLO67ppcQOkN0T4BkceDT0yKhYwzo1DWB4jPvGWm-fmIXf_qqc0TkrE0YwFaTn51I9s--R-2fYruQDpMesKC5AAt2m2nn0HK2RbP--jyF-hfgNM
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3Nb9MwFLdGd4ALYnytMMBCSMAhW5PYcX1AqINVGxKlKgztFjn-GJNKUppWUy_87byXOIGICXatX5Lmffm92P79CHkBbY8QMtQBiyIZQCSKIItwwTWRTFnFFbd4UPjjJDk-ZR_O-NkWmTRnYXBbZZMTq0RtCo3fyA-ga4qhOhhE8u3iR4CsUbi62lBoKE-tYN5UEGM3yHaEyFg9sn14NJnOmtwM0Z0k_gBdLMIDb6_9RZHbffBvROfrTFAVjn-brXuLeVFeVYr-vaPy5jpfqM2lms__mK7Gd8htX2fSUe0YO2TL5nfJjo_kkr7ycNOv75Gf02URnOQOXON7teROL_MVV1Tlho7gZbtj5Xg25XBbS997ahVIEfP5hs5qUntraLahkwbjH_7CuGb0oRc5RRYCS6t1AwoZCz8BlffJ6fjoy7vjwLMyBFpwsQq4RhD2KDRCh1Iq4YxOmI04WNhYaH6Y1TDF6aEOnZMaqscoyQZCK2eZSKC7ih-QXg763iVUxTrmYiCEGcTMSaMUM5JnUeLAQ6Qb9EncmCLVHrIcmTPmabUOJ6B1qbWZogFTb8A-CdqrFjVkx3_kD9HKrSwCblc_FMvz1MdvymCGt5w7Z7hhNowz5ZDbECosK1UkbJ88Qx9J69OrbdpIR0wIpNEZwmOeVxIIupHjrp5ztS7L9OTT12sIfZ51hF56IVeAOrTyJyngnRDMqyO515GE1KE7w7vo0Y1WyvR3kMGVjZdfPUzbYbwp7tTLbbEuUwktOcwCMYg8rGOiVSxUokMG7X6fiE60dDTfHckvvlWQ53E05MmQ98l-G1fXsu2jf7_GY3ILCuCogiiI90hvtVzbJ1BkrrKnPnP8AhQUfWQ
  priority: 102
  providerName: ProQuest
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdG9wAvwPhaYYCFEB8PyRrHjpvH8lFtSJSqUDQeUOQ4zqgIabWkmsrD_nbuEiciMMR44K2Kz258Pp_vcr7fEfIY3B4pQ087nLHQgZ0onZhhwDUIuTJKKGEwUfjtJDiY8zdH4miLfG5yYSwHwUfMlkUVyccfy9zsW07uI15RHT11PV96TQ93BUQuyCgi7D2pEIfwy1iJCUiXyHYgwFTvke35ZDr6VEeamROwgW_T6f40Uue4qlD9W93dwzc7zzD9_X7l5XW-UptTlWU_HV7ja-SsmXZ9Z-Wruy5jV3__BRHyv_HlOrlqzV46qkfZIVsmv0F2rGIp6DOLfv38JjmbniydwzwFSf1W3QCgp3kpFFV5Qkd5uei2FePZVMCwhr6ylV5AY2XZhs7MMRYmMwmNN3TSlByAVxjXBYboIqdYFMHQKoxBQYHiF6niFpmPX394eeDYIhGOlkKWjtCICc-8RGovDJVMEx1wwwQIXGLAF-NGw4mrh9pL01CDMcuCeCC1Sg2XATh7_m3Sy4FFu4QqX_tCDqRMBj5Pw0QpnoQiZkEKAhumgz7xG1mItEVQx0IeWVSFBSV4UjU3I-R5ZHneJ07ba1UjiPyF_gWKWUuL-N_VA1j0yC52xMHgMEKkaSISbjw_VimWWgSDz4SKSdMnD1FIozqZttVi0YhLiVV9hvA3jyoKxADJ8ZLRsVoXRXT47uMFiN7POkRPLVG6BHZoZRM7YE4okx3KvQ4laDLdad5FoW64UgCPwKCEWbEQejbb7Pxm2jbjoHhxMDfLdRGFDEx2CV5An9ypN2XLWDCMh5xxaJGd7drhfLclX3ypENh9NhTBUPSJ227sC63t3X_tcI9cAQudVRgK_h7plSdrcx-s4DJ-YHXZDxfitpk
  priority: 102
  providerName: Unpaywall
Title Pro-Inflammatory wnt5a and Anti-Inflammatory sFRP5 Are Differentially Regulated by Nutritional Factors in Obese Human Subjects
URI https://www.ncbi.nlm.nih.gov/pubmed/22384249
https://www.proquest.com/docview/1323851029
https://www.proquest.com/docview/926157839
https://pubmed.ncbi.nlm.nih.gov/PMC3285685
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0032437&type=printable
https://doaj.org/article/4123e55ffd5d4e13baf1351007e9a27e
http://dx.doi.org/10.1371/journal.pone.0032437
UnpaywallVersion publishedVersion
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVFSB
  databaseName: Free Full-Text Journals in Chemistry
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: HH5
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://abc-chemistry.org/
  providerName: ABC ChemistRy
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: KQ8
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: KQ8
  dateStart: 20061001
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: DOA
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCO Food Science Source
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: A8Z
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/login.aspx?authtype=ip,uid&profile=ehost&defaultdb=fsr
  providerName: EBSCOhost
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: ABDBF
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: DIK
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: GX1
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M~E
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: RPM
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: BENPR
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection (NC LIVE)
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 7X7
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Technology Collection
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 8FG
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/technologycollection1
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 8C1
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M48
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3Pb9MwFLa27gAXxPi1wigWQgIOqRrHjusDQt20MpBWqkJROUWO44xKISlJq9ELfzvPiRMtohM7NIf4uUme3_N7L46_D6FXUPZwLlzlUEKEA57InZCYBVdfUKklk0ybjcIXE_98Tj8t2GIP1ZytVoHFztLO8EnN86T_-9f2PTj8u5K1gbt1p_4qS3UfrNRg7O2jA4hVwpA5XNBmXQG82_ftBrqbehp4YIhjlBh4zWuxqoT0bybuzirJil1Z6b8fV97ZpCu5vZJJci1yje-jezblxKPKRg7Rnk4foEPr1AV-Y5Gn3z5Ef6Z55oASwEp-lqvv-CpdM4llGsFvvWy3FePZlGGZa1yzrMBskSRbnFf89jrC4RanNdw_3IIl98HLFGehLjQuGQJxsQnN26DiEZqPz76enjuWoMFRnPG1w5TBYyduxJUrhORxpHyqCYPBjjTUQVQriHZqqNw4FgoSSeKHA65krCn3odDyHqNOCqo_Qlh6ymN8wHk08GgsIilpJFhI_BiMRcSDLvLqoQiURS83JBpJUC7JcahiKm0GZiwDO5Zd5DS9VhV6x3_kT8woN7IGe7s8keWXgXXlgEKw14zFccQiql0vlLGhOYRkSwtJuO6iF8ZGgmojazODBCPKuWHUGcJlXpYSBn8jNR_4XMpNUQQfP3-7hdCXWUvotRWKM1CHknZTBTyTwfVqSR63JGEWUa3mI2PRtVYK0BE4ATwVEdCztvLdzbhpNn9qPtpLdbYpAgHVOQQED0SeVD7RKLb2sC7iLW9pab7dki5_lOjnHhkyf8i6qN_41a3G9umNN_EM3YU0mJRABd4x6qzzjX4OqeY67KF9vuBwHJ665jj-0EMHJ2eT6axXvrzplbMLnJtPpqPvfwG85YTJ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGeRgviPG1wmAWAgEP6RrHjpsHhAqjatlWprJNfQuuY5dKwSlNq6ov_En8jZzzBRET7GWvvUua-O5-vovt-yH0HMoezgNXOpSQwIFI5M6E2AVXP6BCCSaYsgeFT4Z-_5x-HLPxFvpZnoWx2ypLTMyAOkqk_UZ-AFWTB9lBmwRv598dyxplV1dLCo3cLY7UZg0lW_pmcAj2fUFI78PZ-75TsAo4kjO-dJi0TcSJG3HpBoHgOpI-VYTBE0YKkneqJEC07EhX60BC9kP8SZtLoRXlPlQHHtz3BrpJPcASiB8-rgo8wA7fL47nedw9KLyhNU-MakH02N5_tekvYwmo5oLGPE7SyxLdv_drbq_MXGzWIo7_mAx7d9DtIovF3dztdtCWMnfRToETKX5VNLN-fQ_9OF0kzsBocLxv2YI-XpslE1iYCHfNclaXpb3RKYPbKnxYELcAAMXxBo_U1PKMqQhPNnhYMgjAI_RyviA8M9hyHCicrUpgwEP7gSm9j86vxToPUMPAeO8iLDzpMd7mPGp7VAeREDQK2IT4Gvwv0O0m8kpThLJoiG55OeIwW-XjUBjloxlaA4aFAZvIqa6a5w1B_qP_zlq50rXtvLMfksU0LNAhpJA_KMa0jlhEletNhLbMiZC_qUAQrppo3_pImJ-NrUAp7FLOLUlPB_7mWaZhW3oYu2doKlZpGg4-XVxB6fOopvSyUNIJDIcUxTkNeCfbKqymuVfTBGCSNfGu9ehyVNLwdwjDlaWXXy7Gldje1O4DNCpZpWEABT_MMR6oPMxjohpYyHM7lFCQ8Fq01Ea-LjGzr1lDdY90mN9hTdSq4upKtn3079fYR9v9s5Pj8HgwPHqMbkGqTbJmCN4eaiwXK_UE0tnl5GmGIRh9uW7Q-gWTVbLr
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkIAXxPhaYTALgYCHdK0_4voBocGoVgZjGgztLbiOPSaVpCytpr7wh_HXcZc4gYgJ9rLX3iVNfHc_38X2_Qh5DGWPUrpvI8GYjiASVTRmuOAaa2GckUY6PCj8fjfePhBvD-XhEvlZn4XBbZU1JpZAneYWv5FvQNXEITvoMb3hw7aIva3hy-n3CBmkcKW1ptOoXGTHLU6hfCtejLbA1k8YG7759Ho7CgwDkVVSzSJpsaE466fK9rU2yqc2Fo5JeNrUQSIvnAW4tgPb915byIRYPO4pa7wTKoZKgcN9L5HLinON2wnVYVPsAY7EcTiqx1V_I3hGd5pnrguRhH0AW1NhyRjQzAvL00lenJX0_r138-o8m5rFqZlM_pgYhzfI9ZDR0s3KBVfIkstukpWAGQV9FhpbP79Ffuyd5NEo8-CE38rFfXqazaShJkvpZjY7bsuK4f6ehNs6uhVIXACMJpMF3XdHyDnmUjpe0N2aTQAeYVhxB9HjjCLfgaPlCgUFbMSPTcVtcnAh1rlDljMY71VCDbdcqp5SaY8Lr1NjRKrlmMUefFH7Xofw2hSJDc3RkaNjkpQrfgqKpGo0EzRgEgzYIVFz1bRqDvIf_Vdo5UYXW3uXP-QnR0lAikRALuGk9D6VqXB9PjYeWRQhl3PaMOU6ZB19JKnOyTYAlWwKpZCwZwB_86jUwPYeGQbKkZkXRTL68PkcSh_3W0pPg5LPYTisCWc24J2wbVhLc62lCSBlW-JV9Oh6VIrkdzjDlbWXny2mjRhvinsCM5fPi0RD8Q_zDQeVu1VMNAMLOe9AMAES1YqW1si3Jdnx17K5OmcDGQ9kh3SbuDqXbe_9-zXWyRWAq-TdaHfnPrkGWTcr-yLwNbI8O5m7B5DZzsYPSwih5MtFY9YvRqy3Lg
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdG9wAvwPhaYYCFEB8PyRrHjpvH8lFtSJSqUDQeUOQ4zqgIabWkmsrD_nbuEiciMMR44K2Kz258Pp_vcr7fEfIY3B4pQ087nLHQgZ0onZhhwDUIuTJKKGEwUfjtJDiY8zdH4miLfG5yYSwHwUfMlkUVyccfy9zsW07uI15RHT11PV96TQ93BUQuyCgi7D2pEIfwy1iJCUiXyHYgwFTvke35ZDr6VEeamROwgW_T6f40Uue4qlD9W93dwzc7zzD9_X7l5XW-UptTlWU_HV7ja-SsmXZ9Z-Wruy5jV3__BRHyv_HlOrlqzV46qkfZIVsmv0F2rGIp6DOLfv38JjmbniydwzwFSf1W3QCgp3kpFFV5Qkd5uei2FePZVMCwhr6ylV5AY2XZhs7MMRYmMwmNN3TSlByAVxjXBYboIqdYFMHQKoxBQYHiF6niFpmPX394eeDYIhGOlkKWjtCICc-8RGovDJVMEx1wwwQIXGLAF-NGw4mrh9pL01CDMcuCeCC1Sg2XATh7_m3Sy4FFu4QqX_tCDqRMBj5Pw0QpnoQiZkEKAhumgz7xG1mItEVQx0IeWVSFBSV4UjU3I-R5ZHneJ07ba1UjiPyF_gWKWUuL-N_VA1j0yC52xMHgMEKkaSISbjw_VimWWgSDz4SKSdMnD1FIozqZttVi0YhLiVV9hvA3jyoKxADJ8ZLRsVoXRXT47uMFiN7POkRPLVG6BHZoZRM7YE4okx3KvQ4laDLdad5FoW64UgCPwKCEWbEQejbb7Pxm2jbjoHhxMDfLdRGFDEx2CV5An9ypN2XLWDCMh5xxaJGd7drhfLclX3ypENh9NhTBUPSJ227sC63t3X_tcI9cAQudVRgK_h7plSdrcx-s4DJ-YHXZDxfitpk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pro-inflammatory+wnt5a+and+anti-inflammatory+sFRP5+are+differentially+regulated+by+nutritional+factors+in+obese+human+subjects&rft.jtitle=PloS+one&rft.au=Schulte%2C+Dominik+M&rft.au=M%C3%BCller%2C+Nike&rft.au=Neumann%2C+Katrin&rft.au=Oberh%C3%A4user%2C+Frank&rft.date=2012-02-23&rft.eissn=1932-6203&rft.volume=7&rft.issue=2&rft.spage=e32437&rft_id=info:doi/10.1371%2Fjournal.pone.0032437&rft_id=info%3Apmid%2F22384249&rft.externalDocID=22384249
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon